Mother and son jogging Mother and son jogging Mother and son jogging Mother and son jogging
Advanced Search
  • Apr 18, 2018
    - First-quarter reported sales growth of 16.7 percent; GAAP EPS from continuing operations of $0.23
    - First-quarter organic sales growth of 6.9 percent
    - First-quarter adjusted EPS from continuing operations of $0.59, at the upper end of the previous guidance range
    - Several recently launched products contributing to strong growth
  • Apr 17, 2018
    - Protein is all the rage but new data shows adults 50+ are still missing the mark
    - Packed with 30 grams of high-quality protein and 1 gram of sugar, Ensure Max Protein delivers strength in a bottle
    - Actress Kate Walsh is inspiring adults to join her in making simple nutritional changes to stay active and strong
  • Apr 17, 2018
    - Latest in planned series of cybersecurity updates further strengthens security and performance of implantable cardioverter defibrillators
    - Part of Abbott’s ongoing commitment to continuously advance the security of connected devices and systems
  • Apr 11, 2018
    - Largest-ever randomized trial to evaluate superiority of light-based, three-dimensional imaging (optical coherence tomography (OCT)) versus X-ray-based angiography in patients with complex coronary artery disease who receive a stent
    - Trial will assess if stent procedures guided by high-resolution imaging result in larger vessel diameters and improved patient clinical outcomes versus stent procedures that use standard-of-care imaging
    - Use of OCT imaging may help doctors be more precise in stent implantation
  • Mar 29, 2018
    - THE CARDIOMEMS™ HF SYSTEM IS THE FIRST AND ONLY FDA-APPROVED HEART FAILURE MONITOR PROVEN TO SIGNIFICANTLY REDUCE HEART FAILURE HOSPITAL ADMISSIONS AND IMPROVE QUALITY OF LIFE
    - NEW STUDY WILL EVALUATE WHETHER TREATMENT WITH THE CARDIOMEMS MONITOR IMPROVES SURVIVAL AND OUTCOMES FOR MORE PEOPLE
    - GUIDE-HF IS THE LARGEST HEART FAILURE MEDICAL DEVICE TRIAL IN THE U.S.
Show 5102550100 per page
true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?